Alpha Teknova, Inc. (TKNO)

2.0750 +0.0650 (+3.23%) As of 12:40PM EDT. Market open.

Alpha Teknova, Inc.

2451 Bert Dr.
Hollister, CA 95023
United States
831 637 1100
https://www.teknova.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 210

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Stephen Gunstream	President, CEO & Director	937.79k	N/A	1980
Mr. Matthew C. Lowell	Chief Financial Officer	593.78k	N/A	1971
Mr. Damon A. Terrill	General Counsel, Chief Compliance Officer & Secretary	215.78k	N/A	1971
Ms. Jennifer Henry	Senior Vice President of Marketing	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Alpha Teknova, Inc. produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It provides lab essentials which provides chemical formulations for use in biological research and drug discovery; and clinical solutions, a custom product used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. The company serves its products to life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, as well as academic and government research institutions. Alpha Teknova, Inc. was founded in 1996 and is headquartered in Hollister, California.

Corporate governance

Alpha Teknova, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.